Este frmaco, anlogo de los receptores GLP-1, se fabric inicialmente como antidiabtico
Clinical trials show semaglutide produces approximately 15% average body weight loss, while Saxenda (liraglutide) produces 5-8% on average
Every compounding pharmacy in the GLP-1 space operates under the threat of potential market exclusion
In this respect, owners who are finding the process more challenging might be more resistant to changing the plan, for example, by reducing the daily food portion
However, the relatively short median time required for dose titration (114 days) suggests that the early dose-titration group may have been more likely to benefit from the weight loss associated with oral semaglutide initiation
Selecting the best approach depends on each patients unique clinical profile, AFib type, and overall health goals